MedTrace Logo

Efficacy of Glaucoma Drop Aids in Medication Compliance in the Patient Population at Boston Medical Center

NCT02867995 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 39

Last updated 2019-02-15

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine whether glaucoma drop aids will be cost-effective in delivery of ophthalmic medications by improving medication compliance, visual function, and even decreasing medication waste in the patient population at Boston Medical Center (BMC).

Conditions

Interventions

DEVICE

Eye Drop Aid

Fabrication Autodrop Eye Drop Guide,Owen Mumford OP 6100 Autosqueeze, and the Simply Touch Eye Drop Applicator

Sponsors & Collaborators

  • Boston Medical Center

    lead OTHER

Principal Investigators

  • Manishi Desai, MD · Boston Medical Center

  • Haben Kefella, MD · Boston Medical Center

  • Avni Badami, MD · Boston Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
89 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-03-23
Primary Completion
2018-03-30
Completion
2018-03-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02867995 on ClinicalTrials.gov